Sustaining and supporting both innovation and access are critical issues with significant implications for patients and health systems around the world. PhRMA works, in partnership with international allies, to ensure that the latest innovative medicines are reaching patients wherever they may be. PhRMA also leads advocacy initiatives to inform policymakers and key stakeholders about policies that support patient access to today’s medicines and ensure continued investment in tomorrow’s treatments and cures.